Beacon Biosignals Raises $86 Million to Accelerate AI-Driven Insights into Brain Health
RefinitivLess than 1 min read
Takeda Pharmaceutical Co Ltd 
4502:
BEACON BIOSIGNALS RAISES $86M TO ACCELERATE AI-DRIVEN INSIGHTS INTO BRAIN HEALTH
BEACON BIOSIGNALS: FUNDING ROUND BACKED BY INNOVIVA, GOOGLE VENTURES, NEXUS NEUROTECH VENTURES, S32, TAKEDA & OTHERS
© Copyright Thomson Reuters 2025. Click For Restrictions - https://agency.reuters.com/en/copyright.html
Login or create a forever free account to read this news